St. James Investment Company LLC Invests $16.40 Million in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

St. James Investment Company LLC purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 209,734 shares of the company's stock, valued at approximately $16,397,000. GE HealthCare Technologies makes up approximately 2.8% of St. James Investment Company LLC's portfolio, making the stock its 17th largest holding.

Several other large investors have also recently added to or reduced their stakes in the company. Cathy Pareto & Associates Inc. bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $670,000. Principal Financial Group Inc. raised its holdings in shares of GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after buying an additional 19,010 shares during the last quarter. Everence Capital Management Inc. grew its stake in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company's stock worth $1,475,000 after purchasing an additional 10,220 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its position in shares of GE HealthCare Technologies by 9.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company's stock worth $13,702,000 after buying an additional 12,908 shares in the last quarter. Finally, Apollon Wealth Management LLC lifted its position in GE HealthCare Technologies by 46.5% in the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company's stock worth $1,025,000 after purchasing an additional 4,160 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research analyst reports. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their price target for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $97.73.

GE HealthCare Technologies Stock Down 12.7 %

Shares of NASDAQ GEHC traded down $9.12 during mid-day trading on Friday, reaching $62.88. The company had a trading volume of 9,892,958 shares, compared to its average volume of 2,990,386. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company has a market capitalization of $28.75 billion, a price-to-earnings ratio of 14.48, a PEG ratio of 3.19 and a beta of 1.13. The stock has a fifty day moving average of $85.98 and a two-hundred day moving average of $85.62. GE HealthCare Technologies Inc. has a 12-month low of $58.15 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.22%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's payout ratio is currently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.